Evidence map›Paper›PMID 39451203›Full record

ReviewCells2024

The Extracellular Matrix and Cardiac Pressure Overload: Focus on Novel Treatment Targets.

Matthijs Snelders, Meltem Yildirim, A H Jan Danser, Ingrid van der Pluijm, Jeroen Essers

Abstract readReview
In one paragraph

Review in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Rab10 plays a protective role in the development of pathological cardiac hypertrophy.Journal of molecular and cellular cardiology plus · 2025
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthijs SneldersDepartment of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-6306-9270
Meltem YildirimDepartment of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
A H Jan DanserDivision of Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-5052-3585
Ingrid van der PluijmDepartment of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Jeroen EssersDepartment of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-0605-7211

Funding

Health Holland EMCLSH19005
6 · The paper itself

Abstract

Heart failure is a significant health issue in developed countries, often stemming from conditions like hypertension, which imposes a pressure overload on the heart. Despite various treatment strategies for heart failure, many lack long-term effectiveness. A critical aspect of cardiac disease is the remodeling of the heart, where compensatory changes in the extracellular matrix exacerbate disease progression. This review explores the processes and changes occurring in the pressure-overloaded heart with respect to the extracellular matrix. It further summarizes current treatment strategies, and then focuses on novel treatment targets for maladaptive cardiac remodeling, derived from transverse aortic constriction-induced pressure overload animal models.

Indexed as

Extracellular MatrixHeart FailureAnimalsHumansMyocardiumVentricular Remodelingcardiac remodelingextracellular matrixheart failureinterventionrenin angiotensin system

Identifiers

PMID39451203
PMCPMC11505996

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.